(0.62%) 5 077.75 points
(0.39%) 38 217 points
(0.83%) 17 584 points
(0.80%) $79.63
(2.12%) $1.973
(0.18%) $2 315.10
(-0.25%) $26.68
(0.90%) $963.50
(0.10%) $0.934
(0.24%) $11.06
(0.03%) $0.799
(-1.35%) $92.00
3.70% $ 0.0280
Live Chart Being Loaded With Signals
Pharmaxis Ltd engages in the research, development, and commercialization of healthcare products for the treatment of fibrotic and inflammatory diseases worldwide...
Stats | |
---|---|
Volumen de hoy | 304.00 |
Volumen promedio | 176 420 |
Capitalización de mercado | 20.23M |
EPS | $0 ( 2024-02-07 ) |
Próxima fecha de ganancias | ( $0 ) 2024-07-29 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.400 |
ATR14 | $0.00100 (5.26%) |
Volumen Correlación
Pharmaxis Ltd Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Pharmaxis Ltd Correlación - Moneda/Commodity
Pharmaxis Ltd Finanzas
Annual | 2022 |
Ingresos: | $5.77M |
Beneficio Bruto: | $3.06M (53.06 %) |
EPS: | $-0.0173 |
FY | 2022 |
Ingresos: | $5.77M |
Beneficio Bruto: | $3.06M (53.06 %) |
EPS: | $-0.0173 |
FY | 2022 |
Ingresos: | $7.43M |
Beneficio Bruto: | $7.43M (100.00 %) |
EPS: | $0.0205 |
FY | 2021 |
Ingresos: | $6.68M |
Beneficio Bruto: | $6.68M (100.00 %) |
EPS: | $-0.00700 |
Financial Reports:
No articles found.
Pharmaxis Ltd
Pharmaxis Ltd engages in the research, development, and commercialization of healthcare products for the treatment of fibrotic and inflammatory diseases worldwide. The company operates through two segments, Mannitol Respiratory Business and New Drug Development. It offers Bronchitol, an inhaled dry powder for the treatment of cystic fibrosis; and Aridol, an airways inflammation test that is used to identify twitchy or hyper-responsive airways, as well as to assist in diagnosing and managing asthma. The company's product pipeline consists of oral pan-lysyl oxidase inhibitors (LOX) targeting myelofibrosis and other cancers; topical pan-LOX inhibitors targeting skin scarring after events, such as accidents, surgery,and burns; selective Lysyl Oxidase Like Inhibitors (LOXL2) targeting chronic fibrotic diseases, including kidney fibrosis, pulmonary fibrosis, liver fibrosis, and cardiac fibrosis; and semicarbazide-sensitive amine oxidase for neuro inflammatory diseases. It is also developing Orbital, a dry powder inhaler to deliver high drug doses to lungs. Pharmaxis Ltd was incorporated in 1998 and is headquartered in Frenchs Forest, Australia.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico